Format
Sort by
Items per page

Send to

Choose Destination

Links from Protein

Items: 1 to 20 of 237

1.

Upregulation of long non-coding RNA RAB1A-2 induces FGF1 expression worsening lung cancer prognosis.

Wu D, Yang B, Chen J, Xiong H, Li Y, Pan Z, Cao Y, Chen J, Li T, Zhou S, Ling X, Wei Y, Li G, Zhou Y, Qiu F, Yang L, Lu J.

Cancer Lett. 2018 Dec 1;438:116-125. doi: 10.1016/j.canlet.2018.09.016. Epub 2018 Sep 12.

PMID:
30217564
2.

A novel fibroblast growth factor-1 ligand with reduced heparin binding protects the heart against ischemia-reperfusion injury in the presence of heparin co-administration.

Huang C, Liu Y, Beenken A, Jiang L, Gao X, Huang Z, Hsu A, Gross GJ, Wang YG, Mohammadi M, Schultz JEJ.

Cardiovasc Res. 2017 Nov 1;113(13):1585-1602. doi: 10.1093/cvr/cvx165.

3.

Serum Fibroblast Growth Factor 1 is Associated with the Decreased Risk of Obesity in Human.

Zhu J, Wang Y, Zhu K, Gao J, Wan X, Pang X, Fei S.

Exp Clin Endocrinol Diabetes. 2017 May;125(5):322-326. doi: 10.1055/s-0043-104532. Epub 2017 Mar 16.

PMID:
28303556
4.

Fibroblast Growth Factor 1-Transfected Adipose-Derived Mesenchymal Stem Cells Promote Angiogenic Proliferation.

Hoseini SJ, Ghazavi H, Forouzanfar F, Mashkani B, Ghorbani A, Mahdipour E, Ghasemi F, Sadeghnia HR, Ghayour-Mobarhan M.

DNA Cell Biol. 2017 May;36(5):401-412. doi: 10.1089/dna.2016.3546. Epub 2017 Mar 10.

5.

Computational drill down on FGF1-heparin interactions through methodological evaluation.

Babik S, Samsonov SA, Pisabarro MT.

Glycoconj J. 2017 Jun;34(3):427-440. doi: 10.1007/s10719-016-9745-4. Epub 2016 Nov 17.

6.

Gas-Phase Analysis of the Complex of Fibroblast GrowthFactor 1 with Heparan Sulfate: A Traveling Wave Ion Mobility Spectrometry (TWIMS) and Molecular Modeling Study.

Zhao Y, Singh A, Xu Y, Zong C, Zhang F, Boons GJ, Liu J, Linhardt RJ, Woods RJ, Amster IJ.

J Am Soc Mass Spectrom. 2017 Jan;28(1):96-109. doi: 10.1007/s13361-016-1496-8. Epub 2016 Sep 23.

7.

Engineering a Cysteine-Free Form of Human Fibroblast Growth Factor-1 for "Second Generation" Therapeutic Application.

Xia X, Kumru OS, Blaber SI, Middaugh CR, Li L, Ornitz DM, Sutherland MA, Tenorio CA, Blaber M.

J Pharm Sci. 2016 Apr;105(4):1444-53. doi: 10.1016/j.xphs.2016.02.010.

8.

Identification of new FGF1 binding partners-Implications for its intracellular function.

Bober J, Olsnes S, Kostas M, Bogacz M, Zakrzewska M, Otlewski J.

IUBMB Life. 2016 Mar;68(3):242-51. doi: 10.1002/iub.1480. Epub 2016 Feb 2.

9.

Folding of Fibroblast Growth Factor 1 Is Critical for Its Nonclassical Release.

Prudovsky I, Kacer D, Davis J, Shah V, Jayanthi S, Huber I, Dakshinamurthy R, Ganter O, Soldi R, Neivandt D, Guvench O, Suresh Kumar TK.

Biochemistry. 2016 Feb 23;55(7):1159-67. doi: 10.1021/acs.biochem.5b01341. Epub 2016 Feb 11.

10.

Fibroblast growth factor 1 levels are elevated in newly diagnosed type 2 diabetes compared to normal glucose tolerance controls.

Wang S, Yang Q, Yu S, Pan R, Jiang D, Liu Y, Hu H, Sun W, Hong X, Xue H, Qian W, Wang D, Zhou L, Mao C, Yuan G.

Endocr J. 2016 Apr 25;63(4):359-65. doi: 10.1507/endocrj.EJ15-0627. Epub 2016 Jan 21.

11.

Upregulation of fibroblast growth factor 1 in the synovial membranes of patients with late stage osteoarthritis.

Li R, Wang B, He CQ, Yang YQ, Guo H, Chen Y, Du TH.

Genet Mol Res. 2015 Sep 22;14(3):11191-9. doi: 10.4238/2015.September.22.13.

12.

Clinicopathological significance of fibroblast growth factor 1 in non-small cell lung cancer.

Li J, Wei Z, Li H, Dang Q, Zhang Z, Wang L, Gao W, Zhang P, Yang D, Liu J, Sun Y, Gao W.

Hum Pathol. 2015 Dec;46(12):1821-8. doi: 10.1016/j.humpath.2015.07.022. Epub 2015 Aug 12.

PMID:
26391572
13.

Increased FGF1-FGFRc expression in idiopathic pulmonary fibrosis.

MacKenzie B, Korfei M, Henneke I, Sibinska Z, Tian X, Hezel S, Dilai S, Wasnick R, Schneider B, Wilhelm J, El Agha E, Klepetko W, Seeger W, Schermuly R, Günther A, Bellusci S.

Respir Res. 2015 Jul 3;16:83. doi: 10.1186/s12931-015-0242-2.

14.

Human FGF1 promoter is active in ependymal cells and dopaminergic neurons in the brains of F1B-GFP transgenic mice.

Chen MS, Lin HK, Chiu H, Lee DC, Chung YF, Chiu IM.

Dev Neurobiol. 2015 Mar;75(3):232-48. doi: 10.1002/dneu.22225. Epub 2014 Aug 19.

15.

Importance of the polarity of the glycosaminoglycan chain on the interaction with FGF-1.

Muñoz-García JC, García-Jiménez MJ, Carrero P, Canales A, Jiménez-Barbero J, Martín-Lomas M, Imberty A, de Paz JL, Angulo J, Lortat-Jacob H, Nieto PM.

Glycobiology. 2014 Nov;24(11):1004-9. doi: 10.1093/glycob/cwu071. Epub 2014 Jul 11.

PMID:
25015527
16.

A variant within FGF1 is associated with Alzheimer's disease in the Han Chinese population.

Tao QQ, Sun YM, Liu ZJ, Ni W, Yang P, Li HL, Lu SJ, Wu ZY.

Am J Med Genet B Neuropsychiatr Genet. 2014 Mar;165B(2):131-6. doi: 10.1002/ajmg.b.32205. Epub 2014 Jan 24.

PMID:
24464990
17.

Protease resistant variants of FGF1 with prolonged biological activity.

Kobielak A, Zakrzewska M, Kostas M, Jakimowicz P, Otlewski J, Krowarsch D.

Protein Pept Lett. 2014 May;21(5):434-43.

PMID:
24304385
18.

Fibroblast growth factor-1 is a mesenchymal stromal cell-secreted factor stimulating proliferation of osteoarthritic chondrocytes in co-culture.

Wu L, Leijten J, van Blitterswijk CA, Karperien M.

Stem Cells Dev. 2013 Sep 1;22(17):2356-67. doi: 10.1089/scd.2013.0118. Epub 2013 May 29.

19.

Fibroblast growth factor-1 expression in the endometrium of patients with repeated implantation failure after in vitro fertilization.

Sak ME, Gul T, Evsen MS, Soydinc HE, Sak S, Ozler A, Alabalik U.

Eur Rev Med Pharmacol Sci. 2013 Feb;17(3):398-402.

20.

Pharmacokinetic properties of 2nd-generation fibroblast growth factor-1 mutants for therapeutic application.

Xia X, Babcock JP, Blaber SI, Harper KM, Blaber M.

PLoS One. 2012;7(11):e48210. doi: 10.1371/journal.pone.0048210. Epub 2012 Nov 1.

Supplemental Content

Support Center